Janet V. Cross - Publications

Affiliations: 
Pathology University of Virginia, Charlottesville, VA 
Area:
Cell Biology, Oncology

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Roberts LM, Perez MJ, Balogh KN, Mingledorff G, Cross JV, Munson JM. Myeloid Derived Suppressor Cells Migrate in Response to Flow and Lymphatic Endothelial Cell Interaction in the Breast Tumor Microenvironment. Cancers. 14. PMID 35740673 DOI: 10.3390/cancers14123008  0.49
2018 Balogh KN, Templeton DJ, Cross JV. Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses. Plos One. 13: e0197702. PMID 29864117 DOI: 10.1371/Journal.Pone.0197702  0.674
2017 Dill EA, Gru AA, Atkins KA, Friedman LA, Moore ME, Bullock TN, Cross JV, Dillon PM, Mills AM. PD-L1 Expression and Intratumoral Heterogeneity Across Breast Cancer Subtypes and Stages: An Assessment of 245 Primary and 40 Metastatic Tumors. The American Journal of Surgical Pathology. 41: 334-342. PMID 28195880 DOI: 10.1097/Pas.0000000000000780  0.346
2017 Gottlieb CE, Mills AM, Cross JV, Ring KL. Tumor-associated macrophage expression of PD-L1 in implants of high grade serous ovarian carcinoma: A comparison of matched primary and metastatic tumors. Gynecologic Oncology. PMID 28065619 DOI: 10.1016/j.ygyno.2016.12.021  0.354
2017 Balogh KN, Cross JV. Abstract A03: A role for Macrophage Migration Inhibitory Factor (MIF) in breast cancer growth and metastasis Cancer Immunology Research. 5. DOI: 10.1158/2326-6074.Tumimm16-A03  0.697
2016 Damle SR, Martin RK, Cross JV, Conrad DH. Macrophage migration inhibitory factor deficiency enhances immune response to Nippostrongylus brasiliensis. Mucosal Immunology. PMID 27049059 DOI: 10.1038/Mi.2016.29  0.371
2015 Balogh KN, Cross JV. Abstract A152: The macrophage migration inhibitory factor promotes breast cancer metastasis through interaction with the host immune response Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-A152  0.621
2013 Simpson KD, Cross JV. MIF: metastasis/MDSC-inducing factor? Oncoimmunology. 2: e23337. PMID 23802077 DOI: 10.4161/Onci.23337  0.744
2013 Simpson KD, Templeton DJ, Cross JV. Abstract 2812: Macrophage Migration Inhibitory Factor (MIF) regulates monocytic MDSC abundance to contribute to tumor growth and metastasis. Cancer Research. 73: 2812-2812. DOI: 10.1158/1538-7445.Am2013-2812  0.753
2012 Zhou J, Joplin DG, Cross JV, Templeton DJ. Sulforaphane inhibits prostaglandin E2 synthesis by suppressing microsomal prostaglandin E synthase 1. Plos One. 7: e49744. PMID 23166763 DOI: 10.1371/Journal.Pone.0049744  0.41
2012 Simpson KD, Templeton DJ, Cross JV. Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment. Journal of Immunology (Baltimore, Md. : 1950). 189: 5533-40. PMID 23125418 DOI: 10.4049/Jimmunol.1201161  0.752
2012 Simpson KD, Templeton DJ, Cross JV. Abstract 4369: The macrophage migration inhibitory factor (MIF) contributes to tumor growth and metastasis though interaction with the host immune response Cancer Research. 72: 4369-4369. DOI: 10.1158/1538-7445.Am2012-4369  0.746
2010 Gutierrez GJ, Tsuji T, Cross JV, Davis RJ, Templeton DJ, Jiang W, Ronai ZA. JNK-mediated phosphorylation of Cdc25C regulates cell cycle entry and G(2)/M DNA damage checkpoint. The Journal of Biological Chemistry. 285: 14217-28. PMID 20220133 DOI: 10.1074/Jbc.M110.121848  0.334
2009 Cross JV, Rady JM, Foss FW, Lyons CE, Macdonald TL, Templeton DJ. Nutrient isothiocyanates covalently modify and inhibit the inflammatory cytokine macrophage migration inhibitory factor (MIF) Biochemical Journal. 423: 315-321. PMID 19723024 DOI: 10.1042/Bj20091170  0.464
2007 Cross JV, Foss FW, Rady JM, Macdonald TL, Templeton DJ. The isothiocyanate class of bioactive nutrients covalently inhibit the MEKK1 protein kinase Bmc Cancer. 7. PMID 17894894 DOI: 10.1186/1471-2407-7-183  0.328
2004 Zhang DD, Lo SC, Cross JV, Templeton DJ, Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Molecular and Cellular Biology. 24: 10941-53. PMID 15572695 DOI: 10.1128/Mcb.24.24.10941-10953.2004  0.312
2004 Cross JV, Templeton DJ. Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain. The Biochemical Journal. 381: 675-83. PMID 15139849 DOI: 10.1042/Bj20040591  0.301
Show low-probability matches.